There is a satisfying moment when an idea starts to work: the measurement improves, the prototype behaves, the clinical result looks promising. Then the clinic asks the next questions: for which patients, under what conditions, and with what training?
First, understand what worked.
Early wavefront-guided LASIK research offers a useful example. A 2001 study by Mrochen, Kaemmerer and Seiler connected measurement of optical aberrations with customized laser treatment. The authors reported promising visual results, while also identifying insufficient correction of higher-order aberrations and the need for controlled studies.1
The result established a possibility. Its limitations defined the next development questions.
The difficult cases belong in the evidence.
A later prospective study by Koller, Mrochen and Seiler examined complications and failure after corneal cross-linking, including continued progression and the implications for patient selection.2 Its historical findings should not be treated as present-day advice for an individual patient. They do illustrate a durable scientific responsibility: investigate where a treatment does not perform as hoped.
Investigating failures helps define where a treatment belongs and what needs to change.
The next question is not simply whether something can work, but what must be understood before others can use it reliably.
Then, meet the people who must use it.
The device is only one part of a clinical procedure. Instructions, training, equipment, responsibilities and the environment shape how the procedure is delivered. These are development questions in their own right.
FDA human-factors guidance asks manufacturers to evaluate use with representative users and realistic conditions. Training in validation should resemble the training intended for actual use. Adding another instruction is not, by itself, evidence that a use problem has been solved.3
For investors, these are evidence requirements. For companies, development priorities. For clinic leaders, implementation tasks.
Scaling is a continuing experiment.
As more people and sites become involved, a useful development discipline is to make assumptions explicit: which patients, which users, which resources and which measures of success? Then collect evidence that can challenge those assumptions.
This is an interpretation drawn from the research and guidance, not a claim that any single implementation method guarantees adoption. It suggests a practical sequence: demonstrate the possibility, understand the boundaries, make the procedure usable, and keep learning as delivery expands.
For your next project: What result is reproducible? Which limitation matters most? What must change before others can use it reliably?
Discuss your next development decision →
Sources
- Mrochen M, Kaemmerer M, Seiler T. Clinical results of wavefront-guided LASIK 3 months after surgery. 2001. ↗
- Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. 2009. PMID 19631120; DOI 10.1016/j.jcrs.2009.03.035. ↗
- FDA. Applying Human Factors and Usability Engineering to Medical Devices. ↗